Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
Kos Pharmaceuticals
Abbott
Information provided by:
Foundation Research, Florida
ClinicalTrials.gov Identifier:
NCT00304993
First received: March 17, 2006
Last updated: NA
Last verified: March 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2005
  Estimated Primary Completion Date: No date given